EP4-IN-1

CAS No. 2455480-28-9

EP4-IN-1( —— )

Catalog No. M37063 CAS No. 2455480-28-9

EP4-IN-1 is a potent prostaglandin EP4 receptor inhibitor with potential anti-tumor, anti-inflammatory, and analgesic activities for studying immune and tumor diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 53 In Stock
10MG 88 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EP4-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    EP4-IN-1 is a potent prostaglandin EP4 receptor inhibitor with potential anti-tumor, anti-inflammatory, and analgesic activities for studying immune and tumor diseases.
  • Description
    EP4-IN-1 is a potent prostanoid EP4 receptor inhibitor. EP4-IN-1 is extracted from patent WO2023025270 (example 1), and exhibits prospectin tumor immunity and anti-inflammatory analgesia research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Prostaglandin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2455480-28-9
  • Formula Weight
    440.49
  • Molecular Formula
    C27H24N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (567.55 mM; Ultrasonic )
  • SMILES
    N(C(=O)C1=C2N(CC3=CC=4C(O3)=CC=CC4)C=CC2=CC=C1)C5(C67CC(C(O)=O)(C6)C7)CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Deng qi yuan,et al.Solid form of indole compound, preparation method therefor and use thereof. Patent WO2023025270A1.
molnova catalog
related products
  • AZ-1355

    AZ-1355 is a novel dibenzoxepine derivative with lipid-lowering properties.

  • Ginsenoside Re

    Ginsenoside Re may have properties that inhibit or prevent the growth of tumors.

  • ONO-1301

    A stable, orally active, non-prostanoid prostacyclin I2 (PGI2) mimetic and prostacyclin agonist with inhibitory activity against thromboxane A2 synthase.